| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers Tenders > Headlines for 2023 > News item |
DocMorris/Zur Rose Group accepts 55% of 2.5% bonds for purchase
Chicago, May 26 – DocMorris AG (until recently known as Zur Rose Group AG) announced the tender results for its offer to buy any and all of the CHF 200 million outstanding 2.5% bonds due Nov. 21, 2024 (ISIN: CH0505011897) in a press release.
The company accepted for purchase CHF 109,155,000, or 55%, of the bonds.
The offer purchase price is CHF 4,900 per bond, or 98, plus accrued interest of CHF 65.97.
Payment is scheduled to be delivered on June 1.
The tender offer started on May 12 and expired on May 26.
The purpose of the tender offer is for the company to proactively manage its balance sheets after it closed the sale of its Swiss business.
UBS is the tender agent and dealer manager.
DocMorris, based in Switzerland, is an online pharmacy with markets in Germany and other European countries.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.